Nina R Schooler Selected Research

Excitatory Amino Acid Agents

10/2007

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina R Schooler Research Topics

Disease

48	Schizophrenia (Dementia Praecox) 03/2024 - 01/2002
19	Psychotic Disorders (Schizoaffective Disorder) 04/2024 - 07/2003
5	Treatment-Resistant Schizophrenia 01/2020 - 01/2002
4	Weight Gain 05/2012 - 08/2004
3	Headache (Headaches) 03/2015 - 05/2010
3	Mental Disorders (Mental Disorder) 12/2014 - 11/2007
2	Hallucinations (Hallucination) 01/2020 - 10/2005
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 09/2006
2	Dyslipidemias (Dyslipidemia) 12/2014 - 09/2006
2	Cognitive Dysfunction 08/2013 - 10/2007
2	Obesity 09/2006 - 08/2004
2	Tardive Dyskinesia 08/2004 - 01/2002
1	Tachycardia (Tachyarrhythmias) 05/2016
1	Syndrome (Syndromes) 05/2016
1	Nasopharyngitis 03/2015
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Hypertension (High Blood Pressure) 12/2014
1	Insulin Resistance 12/2014
1	Prediabetic State (Prediabetes) 12/2014
1	Overweight 12/2014
1	Prehypertension 12/2014
1	Abdominal Pain (Pain, Abdominal) 08/2013
1	Tremor (Tremors) 05/2010
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2009
1	Chronic Disease (Chronic Diseases) 04/2009
1	Substance-Related Disorders (Drug Abuse) 11/2007
1	Hyperglycemia 09/2006
1	Fatigue 07/2005
1	Psychomotor Agitation (Akathisia) 08/2004
1	Hyperlipidemias (Hyperlipidemia) 08/2004
1	Myocarditis (Carditis) 08/2004
1	Cataract (Cataracts) 08/2004
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2004
1	Major Depressive Disorder (Major Depressive Disorders) 04/2004
1	Movement Disorders (Movement Disorder) 01/2003

Drug/Important Bio-Agent (IBA)

29	Antipsychotic Agents (Antipsychotics)IBA 03/2024 - 01/2002
11	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 01/2002
10	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 02/2004
3	Polytetrafluoroethylene (Teflon)FDA Link 04/2024 - 01/2016
3	Paliperidone Palmitate FDA Link 01/2018 - 05/2010
3	Olanzapine (Zyprexa)FDA Link 12/2014 - 12/2006
3	Galantamine (Galanthamine)FDA LinkGeneric 08/2013 - 01/2008
2	Antidepressive Agents (Antidepressants)IBA 03/2015 - 02/2005
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 08/2013 - 02/2008
2	Cytidine Diphosphate Choline (Citicoline)IBA 08/2013 - 02/2008
2	ProlactinIBA 05/2012 - 08/2004
2	4,4',5'-trimethylazapsoralenIBA 11/2007 - 04/2004
2	ziprasidone (Geodon)FDA Link 08/2004 - 04/2004
1	Dihydrotachysterol (AT 10)IBA 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Quetiapine Fumarate (Seroquel)FDA Link 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Hemoglobins (Hemoglobin)IBA 12/2014
1	Insulin (Novolin)FDA Link 12/2014
1	Triglycerides (Triacylglycerol)IBA 12/2014
1	PlacebosIBA 08/2013
1	fluphenazine depot (modecate)FDA LinkGeneric 05/2012
1	haloperidol decanoate FDA LinkGeneric 05/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2009
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2008
1	Ligand-Gated Ion ChannelsIBA 02/2008
1	CytidineIBA 01/2008
1	Nicotinic AgonistsIBA 01/2008
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2008
1	Excitatory Amino Acid AgentsIBA 10/2007
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2007
1	Cycloserine (Seromycin)FDA Link 10/2007
1	N-Methylaspartate (NMDA)IBA 10/2007
1	LipidsIBA 09/2006
1	Modafinil (Provigil)FDA Link 07/2005
1	Thioridazine (Mellaril)FDA LinkGeneric 08/2004
1	Mesoridazine (Serentil)FDA Link 08/2004
1	Aripiprazole (Abilify)FDA Link 04/2004
1	Haloperidol (Haldol)FDA LinkGeneric 05/2002

Therapy/Procedure

12	Injections 03/2024 - 10/2009
9	Secondary Prevention 01/2023 - 01/2003
3	Therapeutics 03/2015 - 07/2005
2	Patient Readmission 01/2023 - 04/2016
2	Time-to-Treatment 05/2016 - 10/2005
2	Aftercare (After-Treatment) 10/2007 - 02/2005
2	Drug Therapy (Chemotherapy) 01/2006 - 01/2002
1	Role Playing (Playing, Role) 01/2019
1	Combined Modality Therapy 03/2015
1	Duration of Therapy 12/2014
1	Microspheres (Microsphere) 05/2012
1	Polypharmacy 07/2011